Multicenter evaluation of the NucliSens EasyQ HIV-1 v1.1 assay for the quantitative detection of HIV-1 RNA in plasma

Alaeus, 1997, Subtype specific problems with quantification of plasma HIV-1 RNA, AIDS, 11, 859, 10.1097/00002030-199707000-00004 Bland, 1986, Statistical methods for assessing agreement between two methods of clinical measurement, Lancet, 1, 307, 10.1016/S0140-6736(86)90837-8 Brambilla, 2001, Multisite comparison of reproducibility and recovery from the standard and ultrasensitive Roche Amplicor HIV-1 Monitor assays, J. Clin. Microbiol., 39, 1121, 10.1128/JCM.39.3.1121-1123.2001 Connick, 2000, Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response, J. Infect. Dis., 181, 358, 10.1086/315171 De Mendoza, 1998, False positives for HIV using commercial viral load quantification assays, AIDS, 12, 2076, 10.1097/00002030-199815000-00022 Dyer, 1999, J. Clin. Microbiol., Comparison of NucliSens and Roche Monitor assays for quantitation of levels of HIV type 1 RNA in plasma, 37, 447 Erice, 2000, Performance characteristics of the Quantiplex HIV-1 RNA 3.0 assay for detection and quantitation of HIV type 1 RNA in plasma, J. Clin. Microbiol., 38, 2837, 10.1128/JCM.38.8.2837-2845.2000 Gallant, 2000, Strategies for long-term success in the treatment of HIV infection, JAMA, 283, 1329, 10.1001/jama.283.10.1329 Ginocchio, 2003, Multicenter evaluation of the performance characterisitics of the Nuclisens HIV-1 QT assay used for quantitation of HIV-1 RNA, J. Clin. Microbiol., 41, 164, 10.1128/JCM.41.1.164-173.2003 Hanna, 2003, Drug-selected mutations and non-B subtypes in antiretroviral-naive adults with established HIV infection, J. Infect. Dis., 188, 986, 10.1086/378280 Havlichek, 1999, False-positive HIV diagnosis by HIV-1 plasma viral load testing, Ann. Int. Med., 131, 37, 10.7326/0003-4819-131-10-199911160-00027 Havlir, 2000, Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens, JAMA, 283, 229, 10.1001/jama.283.2.229 Holguín, 2003, HIV-positive immigrants in the Canary Islands Spain: implications for public health in Europe, HIV Clin. Trials, 4, 184, 10.1310/9X1G-MJ6L-PBJN-1PVE Jenny-Avital, 2001, Erroneously low or undetectable plasma HIV-1 RNA load, determined by PCR, in West African and American patients with non-B subtype HIV-1 infection, Clin. Infect. Dis., 32, 1227, 10.1086/319752 Loussert-Ajaka, 1995, Genetic diversity and HIV detection by polymerase chain reaction, Lancet, 346, 912, 10.1016/S0140-6736(95)92762-X Murphy, 2000, Multicenter comparison of Roche Cobas Amplicor Monitor version 1.5, Organon-Teknika Nuclisens QT with extractor, and Bayer Quantiplex version 3.0 for quantification of HIV type 1 RNA in plasma, J. Clin. Microbiol., 38, 4034, 10.1128/JCM.38.11.4034-4041.2000 Nolte, 1998, Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription–PCR for quantitation of HIV type 1 RNA in plasma, J. Clin. Microbiol., 36, 716, 10.1128/JCM.36.3.716-720.1998 Parry, 2001, National surveillance of HIV-1 subtypes for England and Wales, J. Acquir. Immun. Def. Syndr., 26, 381, 10.1097/00126334-200104010-00017 Pozniak, 2003, BHIVA Writing Committee BHIVA Executive Committee. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy, HIV Med., 4, 1, 10.1046/j.1468-1293.4.s1.3.x Raboud, 1998, Suppression of plasma viral load below 20copies/ml is required to achieve a long-term response to therapy, AIDS, 12, 1619, 10.1097/00002030-199813000-00008 Sun, 1998, Ultrasensitive reverse transcription-PCR assay for quantitation of HIV type 1 RNA in plasma, J. Clin. Microbiol., 36, 2964, 10.1128/JCM.36.10.2964-2969.1998 Triques, 1999, Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for quantification of different subtypes of HIV type 1, J. Clin. Microbiol., 37, 110, 10.1128/JCM.37.1.110-116.1999 Tyagi, 1996, Molecular beacons: probes that fluoresce upon hybridisation, Nat. Biotechnol., 14, 303, 10.1038/nbt0396-303 Van Beuningen, 2001, Development of a high throughput detection system for HIV-1 using real-time NASBA based on molecular beacons, 66 Vandamme, 1996, Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV Monitor test, J. Acquir. Immun. Def. Syndr., 13, 127, 10.1097/00042560-199610010-00003 Weusten, 2002, Principles of quantitation of viral loads using nucleic acid sequence-based amplification in combination with homogeneous detection using molecular beacons, Nucl. Acids Res., 30, e26, 10.1093/nar/30.6.e26 Yeni, 2004, Treatment for adult HIV infection 2004 Recommendations of the International AIDS Society-USA Panel, JAMA, 292, 251, 10.1001/jama.292.2.251